NCT01941173 Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy Status WITHDRAWN Phase NA
NCT01928290 Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer Status COMPLETED Phase PHASE2
NCT01897454 Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT01893294 Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01880385 Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer Status UNKNOWN Phase PHASE1
NCT01871571 Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer Status TERMINATED Phase PHASE2
NCT01847326 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01835041 CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01814501 Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab Status COMPLETED Phase PHASE2
NCT01779050 Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Status TERMINATED Phase PHASE2
NCT01747551 FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT01740648 Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer Status COMPLETED Phase PHASE1
NCT01715233 Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. Status COMPLETED Phase PHASE2
NCT01711541 Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01666730 Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01658943 Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT01652196 Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Status COMPLETED Phase PHASE2